LXR modulators
AssigneesBristol-Myers Squibb Company, Exelixis Patent Company LLC
InventorsBrett B. Busch, William C. Stevens, Jr., Ellen K. Kick, Haiying Zhang, Venkataiah Bollu, Richard Martin, Raju Mohan
Life of this patent
Estimating the term…
Abstract
Compounds, pharmaceutically acceptable salts, isomers, or prodrugs thereof, of the invention are disclosed, which are useful as modulators of the activity of liver X receptors (LXR). Pharmaceutical compositions containing the compounds and methods of using the compounds are also disclosed.
Claims30
A compound, isotope, or pharmaceutically acceptable salt thereof, selected from the group consisting of:
- No.
- Name
- 1
- 2-(1-(3′-fluoro-4′-(hydroxymethyl)-5′-(methylsulfonyl)biphenyl-4-yl)-
- 2-(2-(2-fluorophenyl)propan-2-yl)-1H-imidazol-4-yl)propan-2-ol;
- 2
- 2-(2-(2-(2-chloro-6-fluorophenyl)propan-2-yl)-1-(3′-fluoro-4′-
- (hydroxymethyl)-3-methyl-5′-(methylsulfonyl)biphenyl-4-yl)-1H-
- imidazol-4-yl)propan-2-ol;
- 3
- 2-(1-(3-chloro-3′-fluoro-4′-(hydroxymethyl)-5′-(methylsulfonyl)bi-
- phenyl-4-yl)-2-(2-(2,6-dichlorophenyl)propan-2-yl)-1H-imidazol-4-
- yl)propan-2-ol;
- 4
- 2-(2-(2-(2-chloro-3-fluorophenyl)propan-2-yl)-1-(3′-fluoro-4′-
- (hydroxymethyl)-5′-(methylsulfonyl)biphenyl-4-yl)-1H-imidazol-4-
- yl)propan-2-ol;
- 5
- 2-(2-(2-(2,6-dichlorophenyl)propan-2-yl)-1-(3′-fluoro-4′-(hydroxy-
- methyl)-5′-(methylsulfonyl)biphenyl-4-yl)-1H-imidazol-4-yl)propan-
- 2-ol;
- 6
- 2-(2-(2-(2-Chloro-phenyl)propan-2-yl)-1-(3,3′-difluoro-4′-hydroxy-
- methyl-5′-(methylsulfonyl)biphenyl-4-yl)-1H-imidazol-4-yl)-propan-
- 2-ol;
- 7
- 2-(2-(2-(2-chloro-6-fluorophenyl)propan-2-yl)-1-(3,3′-difluoro-4′-
- (hydroxymethyl)-5′-(methylsulfonyl)biphenyl-4-yl)-1H-imidazol-4-
- yl)propan-2-ol;
- 8
- 2-{1-(3,3′-Difluoro-4′-hydroxymethyl-5′-methanesulfonyl-biphenyl-
- 4-yl)-2-[2-(2-fluorophenyl)propan-2-yl]-1H-imidazol-4-yl}-propan-
- 2-ol;
- 9
- 2-(2-(2-(2,6-dichlorophenyl)propan-2-yl)-1-(3,3′-difluoro-4′-
- (hydroxymethyl)-5′-(methylsulfonyl)biphenyl-4-yl)-1H-imidazol-
- 4-yl)propan-2-ol;
- 10
- 2-(2-(2-(2,6-dichlorophenyl)propan-2-yl)-1-(3,3′-difluoro-4′-
- (hydroxymethyl)-5′-(methylsulfonyl)biphenyl-4-yl)-1H-imidazol-4-
- yl)[(13CD3)2]propan-2-ol;
- 11
- 2-(2-(2,4-dichlorobenzyl)-1-(3,3′-difluoro-4′-(hydroxymethyl)-5′-
- (methylsulfonyl)biphenyl-4-yl)-1H-imidazol-4-yl)propan-2-ol;
- 12
- 2-(1-(3,3′-difluoro-4′-(hydroxymethyl)-5′-(methylsulfonyl)biphenyl-
- 4-yl)-2-(2-(trifluoromethyl)benzyl)-1H-imidazol-4-yl)propan-2-ol;
- 13
- 2-(1-(3-chloro-3′-fluoro-4′-(hydroxymethyl)-5′-(methylsulfonyl)bi-
- phenyl-4-yl)-2-(2-chloro-4-fluorobenzyl)-1H-imidazol-4-yl)propan-
- 2-ol;
- 14
- 2-(2-(2-chloro-4-fluorobenzyl)-1-(3,3′-difluoro-4′-(hydroxymethyl)-
- 5′-(methylsulfonyl)biphenyl-4-yl)-1H-imidazol-4-yl)propan-2-ol;
- 15
- 2-(2-(2,4-dichlorobenzyl)-1-(3′-fluoro-4′-(hydroxymethyl)-5′-
- (methylsulfonyl)biphenyl-4-yl)-1H-imidazol-4-yl)propan-2-ol;
- 16
- 2-(1-(3,3′-difluoro-4′-(hydroxymethyl)-5′-(methylsulfonyl)biphenyl-
- 4-yl)-2-(2-fluorobenzyl)-1H-imidazol-4-yl)propan-2-ol;
- 17
- 2-(1-(3′-fluoro-4′-(hydroxymethyl)-5′-(methylsulfonyl)biphenyl-4-
- yl)-2-(2-methylbenzyl)-1H-imidazol-4-yl)propan-2-ol;
- 18
- 2-(2-(2,6-dichlorobenzyl)-1-(3′-fluoro-4′-(hydroxymethyl)-5′-
- (methylsulfonyl)biphenyl-4-yl)-1H-imidazol-4-yl)propan-2-ol;
- 19
- 2-[2-(2-Chloro-5-fluoro-benzyl)-1-(3′-fluoro-4′-hydroxymethyl-5′-
- methanesulfonyl-biphenyl-4-yl)-1H-imidazol-4-yl]-propan-2-ol;
- 20
- 2-[2-(2-Chloro-benzyl)-1-(3,3′-difluoro-4′-hydroxymethyl-5′-
- methanesulfonyl-biphenyl-4-yl)-1H-imidazol-4-yl]-propan-2-ol;
- [[or]] and
- 21
- 2-{2-[1-(2,6-dichlorophenyl)ethyl]-1-[3,3′-difluoro-4′-(hydroxy-
- methyl)-5′-(methylsulfonyl)biphenyl-4-yl]-1H-imidazol-4-yl}propan-
- 2-ol.
A compound, isotope, or pharmaceutically acceptable salt thereof, which is 2-(1-(3-chloro-3′-fluoro-4′-(hydroxymethyl)-5′-(methylsulfonyl)biphenyl-4-yl)-2-(2-(2,6-dichlorophenyl)propan-2-yl)-1H-imidazol-4-yl)propan-2-ol.
A compound, isotope, or pharmaceutically acceptable salt thereof, which is 2-(2-(2-(2,6-dichlorophenyl)propan-2-yl)-1-(3,3′-difluoro-4′-(hydroxymethyl)-5′-(methylsulfonyl)biphenyl-4-yl)-1H-imidazol-4-yl)propan-2-ol.
Dependencies are inferred from the claim text.